Hunter, Rose Published in Intellectual Property Magazine About Overcoming Challenges to Patent Eligibility
16 July 2020
Intellectual Property Magazine
Partner Paul Hunter and Senior Counsel Daniel Rose were published in Intellectual Property Magazine. Their article, “Moving Target,” discussed approaches to overcoming challenges to patent eligibility in light of recent jurisprudence and inconsistent policy.
“Patent eligibility defines what can be patented. Over the past decade, the standard for such eligibility in the US has been a moving target with courts and the US Patent and Trademark Office (USPTO) lacking a consistent voice. Only recently have jurisprudence and the USPTO found similar approaches to assessing eligibility,” they wrote.
“After four decisions on patent subject matter eligibility in the early 2010s – Bilski, Mayo, Myriad, and Alice – the Supreme Court of the US has sat on the sidelines and let the Federal Circuit and the USPTO hash out the details of this developing area of law. The Justices have declined to hear any eligibility questions this term, even rejecting an appeal from the Federal Circuit’s en banc denial for rehearing in Athena v Mayo this past summer that resulted in nine separate opinions. Lower courts and the USPTO have struggled with confusing and inconsistent precedent, resulting in a lack of clarity and predictability.”
Read the full article here.
(Subscription required)
“Patent eligibility defines what can be patented. Over the past decade, the standard for such eligibility in the US has been a moving target with courts and the US Patent and Trademark Office (USPTO) lacking a consistent voice. Only recently have jurisprudence and the USPTO found similar approaches to assessing eligibility,” they wrote.
“After four decisions on patent subject matter eligibility in the early 2010s – Bilski, Mayo, Myriad, and Alice – the Supreme Court of the US has sat on the sidelines and let the Federal Circuit and the USPTO hash out the details of this developing area of law. The Justices have declined to hear any eligibility questions this term, even rejecting an appeal from the Federal Circuit’s en banc denial for rehearing in Athena v Mayo this past summer that resulted in nine separate opinions. Lower courts and the USPTO have struggled with confusing and inconsistent precedent, resulting in a lack of clarity and predictability.”
Read the full article here.
(Subscription required)
People
Related News
13 February 2025
In the News
Gregory Husisian on USMCA Viability – 'The question is in what form?'
Foley & Lardner LLP partner Gregory Husisian assessed the viability of the U.S. – Mexico – Canada Agreement (USMCA) in the IndustryWeek article, “As Tariffs Concerns Grow, Where Is the USMCA?“
13 February 2025
In the News
Nikhil Pradhan on FDA Draft AI Drug Guidance – 'The industry is very much evolving'
Foley & Lardner LLP senior counsel Nikhil Pradhan shared insight on recent draft guidance from the U.S. Food and Drug Administration's in the MedCentral article, "FDA Draft Guidance Addresses Drug Submissions that Use AI Data."
12 February 2025
In the News